Table 1.
Plaque scores of the atherosclerosis after drug treatment*
| Drug | No. | Code | Plaque scores before | Plaque scores after | Δ | % of reduction |
|---|---|---|---|---|---|---|
| treatmenta (mm) | treatmentb (mm) | (b-a) | (b-a)/a*100 | |||
| BBR | 1 | Y GY | 1.6 | 1.5 | −0.1 | – |
| 2 | G DW | 14.8 | 14.1 | −0.7 | – | |
| 3 | L JM | 5.9 | 6 | 0.1 | – | |
| 4 | L ZF | 4.8 | 4.9 | 0.1 | – | |
| 5 | C K | 7.6 | 7.1 | −0.5 | – | |
| 6 | T WM | 16.5 | 15.8 | −0.7 | – | |
| 7 | W YH | 2.0 | 2.0 | 0 | – | |
| 8 | L KJ | 4.3 | 4.1 | −0.2 | – | |
| 9 | K LH | 1.5 | 1.5 | 0 | – | |
| 10 | Z LY | 2.0 | 1.6 | −0.4 | – | |
| 11 | L CX | 2.9 | 2.8 | −0.1 | – | |
| 12 | F XL | 4.2 | 4.1 | −0.1 | – | |
| 13 | L R | 1.5 | 1.7 | 0.2 | – | |
| 14 | W SC | 2.8 | 3.2 | 0.4 | – | |
| 15 | C JR | 31.6 | 30.8 | −0.8 | – | |
| 16 | C LJ | 2.2 | 1.9 | −0.3 | – | |
| 17 | Y XY | 7.9 | 8.1 | 0.2 | – | |
| 18 | S HB | 4.9 | 5.4 | 0.5 | – | |
| 19 | Y CR | 2.2 | 2.2 | 0 | – | |
| 20 | S LT | 10.2 | 10 | −0.2 | – | |
| 21 | Q SF | 6.5 | 4.7 | −1.8 | – | |
| Mean | 6.57 | 6.36 | −0.21 | −3.2 | ||
| Statins | 1 | W JT | 6.1 | 5.8 | −0.3 | – |
| 2 | Z WT | 14.3 | 9.4 | −4.9 | – | |
| 3 | H Z | 14.4 | 18.8 | 4.4 | – | |
| 4 | L SQ | 5.0 | 4.7 | −0.3 | – | |
| 5 | Z YL | 8.3 | 7.8 | −0.5 | – | |
| 6 | L SH | 4.2 | 4.6 | 0.4 | – | |
| 7 | L W | 2.8 | 3.5 | 0.7 | – | |
| 8 | S BJ | 5.6 | 9.0 | 3.4 | – | |
| 9 | L JL | 7.4 | 7.0 | −0.4 | – | |
| 10 | L CL | 14.5 | 20.4 | 5.9 | – | |
| 11 | X ZQ | 20.7 | 15.4 | −5.3 | – | |
| 12 | L ZE | 4.4 | 3.3 | −1.1 | – | |
| Mean | 8.98 | 9.14 | 0.17 | 1.9 |
#China Clinical Trial Registry: ChiCTR-OPN-17012942.